应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ACOG ALPHA COGNITION INC
盘前交易 11-03 04:36:51 EST
8.34
-0.40
-4.58%
最高
8.95
最低
8.32
成交量
5.73万
今开
8.85
昨收
8.74
日振幅
7.27%
总市值
1.81亿
流通市值
1.26亿
总股本
2,174万
成交额
48.71万
换手率
0.38%
流通股本
1,506万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Alpha Cognition宣布首位患者入组评估Zunveyl®用于轻中度阿尔茨海默病的Resolve第四期研究
美股速递 · 06-16
Alpha Cognition宣布首位患者入组评估Zunveyl®用于轻中度阿尔茨海默病的Resolve第四期研究
Alpha Cognition:八成Zunveyl患者精神药物使用出现延迟或中断
美股速递 · 06-09
Alpha Cognition:八成Zunveyl患者精神药物使用出现延迟或中断
Alpha Cognition公布Zunveyl®治疗阿尔茨海默病Beacon真实世界研究积极顶线结果
美股速递 · 06-09
Alpha Cognition公布Zunveyl®治疗阿尔茨海默病Beacon真实世界研究积极顶线结果
Alpha Cognition Inc.2024财年第三财季实现净利润-1.86百万美元,同比增加43.98%
市场透视 · 2024-11-24
Alpha Cognition Inc.2024财年第三财季实现净利润-1.86百万美元,同比增加43.98%
加载更多
公司概况
公司名称:
ALPHA COGNITION INC
所属市场:
NASDAQ
上市日期:
--
主营业务:
Alpha Cognition Inc.于2017年11月15日根据《不列颠哥伦比亚省商业公司法》(“BCBCA”)成立,名称为“Crystal Bridge Enterprises Inc.”,为加拿大资本联营公司。他们于2021年3月18日完成了与Alpha Cognition Canada Inc.的合格交易,并将其名称更改为Alpha Cogning股份有限公司。Alpha Cognition, Inc.是一家商业化前阶段的生物制药公司,致力于为阿尔茨海默病等神经退行性疾病患者开发治疗方法。
发行价格:
--
{"stockData":{"symbol":"ACOG","market":"US","secType":"STK","nameCN":"ALPHA COGNITION INC","latestPrice":8.34,"timestamp":1793653200000,"preClose":8.74,"halted":0,"volume":57339,"delay":0,"changeRate":-0.04576659038901606,"floatShares":15056000,"shares":21742100,"eps":-1.0868,"marketStatus":"盘前交易","change":-0.4,"latestTime":"11-03 04:36:51 EST","open":8.85,"high":8.95,"low":8.315,"amount":487089.472473,"amplitude":0.072654,"askPrice":9.82,"askSize":100,"bidPrice":8.15,"bidSize":800,"shortable":3,"etf":0,"ttmEps":-1.0868,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793716200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":8.34,"postHourTrading":{"tag":"盘后","latestPrice":8.34,"preClose":8.34,"latestTime":"19:30 EST","volume":3,"amount":25.02,"timestamp":1793665802950,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6366981721431824,"impliedVol":1.275,"impliedVolPercentile":0.6575},"requestUrl":"/m/hq/s/ACOG","defaultTab":"news","newsList":[{"id":"1150085578","title":"Alpha Cognition宣布首位患者入组评估Zunveyl®用于轻中度阿尔茨海默病的Resolve第四期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1150085578","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150085578?lang=zh_cn&edition=full","pubTime":"2026-06-16 20:30","pubTimestamp":1781613054,"startTime":"0","endTime":"0","summary":"Alpha Cognition Inc.宣布,其Resolve第四期研究已迎来首位患者入组。这项研究旨在评估Zunveyl®在轻至中度阿尔茨海默病患者中的疗效与安全性。该里程碑标志着公司在该药物临床开发进程中的关键一步,为后续数据收集与分析奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181886473","title":"Alpha Cognition:八成Zunveyl患者精神药物使用出现延迟或中断","url":"https://stock-news.laohu8.com/highlight/detail?id=1181886473","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181886473?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:01","pubTimestamp":1781006473,"startTime":"0","endTime":"0","summary":"根据医疗服务提供者的报告,在使用Zunveyl的患者中,高达80%的人其精神类药物的使用出现了延迟或中断的情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ACOG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124277263","title":"Alpha Cognition公布Zunveyl®治疗阿尔茨海默病Beacon真实世界研究积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1124277263","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1124277263?lang=zh_cn&edition=full","pubTime":"2026-06-09 20:00","pubTimestamp":1781006423,"startTime":"0","endTime":"0","summary":"ALPHA COGNITION INC宣布,其Zunveyl®用于治疗阿尔茨海默病的Beacon真实世界研究取得了积极的顶线结果。这一进展为该公司在该领域的研发提供了重要的临床数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2485200544","title":"Alpha Cognition Inc.2024财年第三财季实现净利润-1.86百万美元,同比增加43.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485200544","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2485200544?lang=zh_cn&edition=full","pubTime":"2024-11-24 00:00","pubTimestamp":1732377620,"startTime":"0","endTime":"0","summary":"11月24日,Alpha Cognition Inc.公布财报,公告显示公司2024财年第三财季净利润为-1.86百万美元,同比增加43.98%;其中营业收入为0.00美元,每股基本收益为-0.31美元。从资产负债表来看,Alpha Cognition Inc.总负债7.95百万美元,其中短期债务1.21百万美元,资产负债比为0.64,流动比率为1.50。机构评级:截至2024年11月24日,当前有1家机构对Alpha Cognition Inc.目标价做出预测,其中目标均价为36.13美元,其中最低目标价为36.13美元,最高目标价为36.13美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000028abd9b88e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241124000028abd9b88e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACOG","ACOGF","ACOGD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphacognition.com","stockEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.0835},{"period":"3month","weight":-0.0671},{"period":"6month","weight":0.3072},{"period":"1year","weight":0.3473},{"period":"ytd","weight":0.2831}],"compareEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0228},{"period":"3month","weight":-0.0249},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.1027},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alpha Cognition Inc.于2017年11月15日根据《不列颠哥伦比亚省商业公司法》(“BCBCA”)成立,名称为“Crystal Bridge Enterprises Inc.”,为加拿大资本联营公司。他们于2021年3月18日完成了与Alpha Cognition Canada Inc.的合格交易,并将其名称更改为Alpha Cogning股份有限公司。Alpha Cognition, Inc.是一家商业化前阶段的生物制药公司,致力于为阿尔茨海默病等神经退行性疾病患者开发治疗方法。","exchange":"NASDAQ","name":"ALPHA COGNITION INC","nameEN":"ALPHA COGNITION INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ALPHA COGNITION INC(ACOG)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ALPHA COGNITION INC(ACOG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ALPHA COGNITION INC,ACOG,ALPHA COGNITION INC股票,ALPHA COGNITION INC股票老虎,ALPHA COGNITION INC股票老虎国际,ALPHA COGNITION INC行情,ALPHA COGNITION INC股票行情,ALPHA COGNITION INC股价,ALPHA COGNITION INC股市,ALPHA COGNITION INC股票价格,ALPHA COGNITION INC股票交易,ALPHA COGNITION INC股票购买,ALPHA COGNITION INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ALPHA COGNITION INC(ACOG)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ALPHA COGNITION INC(ACOG)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}